GE HealthCare Technologies (GEHC) EBT Margin (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly EBT Margin came in at 13.09% in Q2 2026, up 84.0% YoY from 7.11% in Q2 2025, and up 32.98% on a QoQ basis from 9.84% in Q1 2026.
GE HealthCare Technologies (GEHC) EBT Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of EBT Margin data on file, last reported at 13.09% in Q2 2026.
- Quarterly EBT Margin rose 84.0% year-over-year to 13.09% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 12.52% (down 149.0% YoY) and the FY2025 annual result came in at 13.42%, up 30.0% from the prior year.
- EBT Margin climbed to 13.09% in Q2 2026, from 9.84% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 15.68% in Q4 2024 to a low of 9.84% in Q1 2026.
- A 5-year average of 12.87% and a median of 12.8% in 2026 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin surged 398 bps — and 2026, when it sank 464 bps.
- Tracing GEHC's EBT Margin over 5 years: stood at 14.54% in 2022, then retreated by 20 bps to 11.7% in 2023, then surged by 34 bps to 15.68% in 2024, then slipped by 8 bps to 14.41% in 2025, then declined by 9 bps to 13.09% in 2026.
- The last three EBT Margin figures came in at 13.09% (Q2 2026), 9.84% (Q1 2026), and 14.41% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.32% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 11.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.09% |
| Mar 31, 2026 | 9.84% |
| Dec 31, 2025 | 14.41% |
| Sep 30, 2025 | 12.50% |
| Jun 30, 2025 | 12.24% |
| Mar 31, 2025 | 14.49% |
| Dec 31, 2024 | 15.68% |
| Sep 30, 2024 | 13.53% |
| Jun 30, 2024 | 11.94% |
| Mar 31, 2024 | 11.01% |
| Dec 31, 2023 | 11.70% |
| Sep 30, 2023 | 13.19% |
| Jun 30, 2023 | 11.83% |
| Mar 31, 2023 | 11.60% |
| Dec 31, 2022 | 14.54% |
| Sep 30, 2022 | 13.59% |
| Jun 30, 2022 | 14.25% |
| Mar 31, 2022 | 12.27% |